2021 annual financial data

Acumen Pharmaceuticals, Inc. - Common Stock 2021 Operating margin

Acumen Pharmaceuticals, Inc. - Common Stock 2021 operating margin with verified…

Direct answer

Operating margin was -1,363.79%.

Operating income was -19,584,000 USD and net income was -100,606,000 USD.
Operating cash flow was -17,961,000 USD.

Verified data

Revenue
1,436,000 USD
Operating income
-19,584,000 USD
Net income
-100,606,000 USD
Operating cash flow
-17,961,000 USD